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Metagenomic approaches applied to viruses have highlighted their prevalence in almost
all microbial ecosystems investigated. In all ecosystems, notably those associated with
humans or animals, the viral fraction is dominated by bacteriophages. Whether they
contribute to dysbiosis, i.e., the departure from microbiota composition in symbiosis at
equilibrium and entry into a state favoring human or animal disease is unknown at present.
This review summarizes what has been learnt on phages associated with human and
animal microbiota, and focuses on examples illustrating the several ways by which phages
may contribute to a shift to pathogenesis, either by modifying population equilibrium, by
horizontal transfer, or by modulating immunity.
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INTRODUCTION
Parallel to the development of metagenomics studies on micro-
bial ecosystems (Lepage et al., 2013), specific approaches for
the description of the viral fraction of these ecosystems have
emerged in the recent years, resulting in the description of vari-
ous ecosystem “viromes.” These observations have highlighted the
remarkable importance of viruses in all studied microbial ecosys-
tems since their description in the Sargasso sea samples (Angly
et al., 2006). Their high diversity was in particular described in
microbial communities living in symbiosis with the human body
such as the digestive tract (Reyes et al., 2010; Minot et al., 2011),
the human saliva (Pride et al., 2012), the respiratory tract (Willner
et al., 2009) or the skin (Foulongne et al., 2012), but also animal
microbiota, such as in the cow rumen (Berg Miller et al., 2012),
or in the pig digestive tract (Shan et al., 2011). Interestingly, such
metagenomic approaches allow the recovery of viruses from the
three kingdoms of life, which are seldom looked at together. In
most of the above mentioned cases, the viral fraction is essentially
composed of viruses of bacteria, also designated as bacteriophages
(or phages for short). This appears not to be the case for the
human skin virome, where eukaryotic viruses were reported to be
dominant, but the sample preparation did not include the steps
needed to recover fully the bacterial viruses (Foulongne et al.,
2012). Indeed, critical to the appropriate interpretation of virome
studies is the technique used to purify virus particles away from
other DNA and RNA sources, and extract their genetic content
(Roux et al., 2013). A recent survey exposes the key technologi-
cal issues and summarizes what has been learnt by applying such
techniques to the human gut viral fraction (Reyes et al., 2012).
These various virome studies have naturally fostered a renewed
interest for the possible impact of bacterial viruses on ecosystems.
The influence of phages on bacterial ecosystems is manifold,
and for a comprehensive reading on their influence in shaping
the mammalian gut microbiota, readers are referred to a recent
review (Mills et al., 2013). Here we more specifically address
the possible contribution of phages to the shift from health to
disease in humans and animals with emphasis on the digestive
tract ecosystem. The gut microbiota is a very complex microbial
ecosystem, comprised of more than 500 species living in eubiosis
with their host; i.e., with mutual benefit. Over the past decade,
an increasing number of studies have indicated that changes in
the abundance of bacterial species, or imbalance of the dynamic
equilibrium in bacterial composition, are linked to several human
disorders. A contribution of phages to the shift from health to dis-
ease could be related to their potential involvement in dysbiosis, a
term which designates the rupture of eubiosis (see several defini-
tions in Box 1). However, up to now, very few examples of phage
contribution to a change in microbiota composition have been
reported. Here, we present concepts and related data useful to
understand this emerging field of research. Much more is known
on the contribution of phages to disease via their introduction
into the bacterial genome, and expression of phage genes dramat-
ically changing bacterial phenotypes. Such modification is known
as lysogenic conversion, and famous examples include toxin genes
such as the Panton-Valentine, cholera, Shiga- and diphtheria tox-
ins. Combined with the capacity of temperate phages to spread
from one bacterial host to another, it can lead to the emergence
of new pathogenic bacterial strains (Brussow et al., 2004; Tinsley
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Box 1 | Glossary
Microbiota: A microbial community, including bacteria, archaea, eukarya, and viruses, which occupies a given habitat.
Metagenomics: The study of metagenomes, genetic material recovered directly from environmental samples. Metagenomics is the
genomic analysis (analysis of the entire DNA in an organism) applied to all the microorganisms of a microbial ecosystem without previous
identification. Metagenomics is an emerging field encompassing culture-independent studies of the structures and functions of microbial
communities and their interactions with the habitats they occupy to understand their biological diversity.
Dysbiosis: Alteration of the microbiota in comparison to the normal, healthy state. Dysbiosis refers to a condition of microbial imbalances
compared with the “eubiosis” condition, a state of equilibrium between bacterial symbionts and pathobionts. Dysbiosis is mostly reported
in the digestive tract or on the skin, but can also occur on any exposed surface or mucous membrane. Dysbiosis can be observed at
several analytical levels, from diversity to compositional or functional imbalances.
Symbiosis: from the Greek “sym”—together—and “bioo”-living-, designates a stable and intimate association between two or more
organisms belonging to different species. The organisms are designated as symbionts, the larger one can also be named the host. A
symbiosis does not include necessarily the idea of reciprocal benefit, which is designated by mutualism.
Pathobionts: strains of the gut microbiota that are harmless in healthy individuals but become pathogen upon major shifts such as antibio-
therapy, or the weakening of host immunity. All pathobionts are opportunistic pathogens, but conversely, some opportunistic pathogens
may not be part of the healthy gut microbiota. The term was coined in 2009 by Round and Mazmanian (2009).
Monoxenic mice: Germ-free mice maintained in sterile incubators that have been fed with a single bacterial species, that establishes a
symbiosis with the gut.
et al., 2006; Fortier and Sekulovic, 2013). A recent and dramatic
case of such emergence is the Escherichia coli O104:H4 strain
which acquired a Shiga-toxin encoding phage, and caused an out-
break in Germany in 2011 (Muniesa et al., 2012). Finally, phages
can also impact the host immune response, either directly or by
modifying the antigenicity of bacteria.
ABUNDANCE, DIVERSITY, LOCALIZATION OF PHAGES IN THE
DIGESTIVE TRACT
Lysis and lysogeny
Phages essentially belong to two categories, virulent and temper-
ate. The virulent phage life cycle consists in replicating in, and
then lysing their bacterial host (Figure 1A, steps 1–5). Temperate
phages can alternate between two life styles: they either lyse their
host, like virulent phages, or establish a symbiosis with it, the
so-called lysogeny state (Figure 1A steps 6 and 7), by entering
into the bacterial genome and expressing only a small subset of
their genes (among which, for instance, the above mentioned tox-
ins). Upon infection in a given bacterial population, the fraction
of temperate phages entering into lysogeny varies with the bac-
terium physiology, and is generally low, compared to the fraction
going into lysis. In the condition of lysogeny, the phage is named
“prophage,” and the bacterium hosting the phage is said to be
lysogenic for this phage. The study of naturally occurring signals
triggering the shift back from the symbiosis life style to the lytic
one (Figure 1A, step 8) is an ongoing field of research. Known
signals of prophage induction are mainly related to DNA dam-
age (Monk and Kinross, 1975), but temperature (Matos et al.,
2013) and oxidative stress (Figueroa-Bossi and Bossi, 1999; Selva
et al., 2009; Los et al., 2010) can also lead to the destruction
of the main repressor protein in charge of lysogeny mainte-
nance, triggering excision of the prophage, and its entry into the
lytic cycle. In consequence, some antibiotics such as quinolones,
because they provoke DNA injury in bacteria, induce prophages
(Cowlishaw and Ginoza, 1970). Typical of the intricacy of mobile
genetic element regulations, prophages are also induced upon
bacterial conjugation, when their DNA enters into a bacterial
cytoplasm devoid of phage repressor protein (Jacob andWollman,
1954). It was also suggested recently that the general quorum
sensing molecule N-acyl homoserine lactone (AHL) may induce
prophages (Ghosh et al., 2009), but subsequent analysis revealed
that the AHL effect was rather to repress phage receptor synthesis,
thereby artificially increasing the free phage fraction (Hoyland-
Kroghsbo et al., 2013). Even in the absence of apparent signal,
prophages are induced at low levels so that laboratory saturated
pure cultures (109 bacteria per ml) typically contain between 104
and 107 phage articles per ml (Figure 1B).
Some phage-encoded toxins can be produced by bacteria
during lysogeny, but in at least two situations, the Shiga-toxin
of enterobacteria and the platelet binding protein (Pbl) of
Streptococcus mitis, the phage-encoded virulence factors are pro-
duced only during the lytic cycle (Mitchell et al., 2007; Tyler et al.,
2013). Once released, the Pbl toxin, which is a tail fiber pro-
tein, associates with the bacterial surface and permits its adhesion
to platelet cells (Mitchell et al., 2007). Some prophages disrupt
bacterial genes, which are restored upon phage excision leading
to another type of phenotypic change (Rabinovich et al., 2012).
Poly-lysogenic strains can therefore exhibit a whole range of phe-
notypes depending on which prophage is excised, and/or induced
up to complete lysis at any time (Asadulghani et al., 2009; Matos
et al., 2013). This is illustrated in Figure 1B, showing a population
of poly-lysogens under its various potential states: (1) production
of background levels of virions, (2) excision of a prophage and
appearance of a new phenotype by restoration of the gene that
was interrupted by the prophage, (3) adsorbtion of virions at
the bacterial surface and use as virulence factors (Mitchell et al.,
2007). These general notions are important when considering the
impact of phages on ecosystems: the effect of temperate phages
on a given microbiota will be profoundly different from that of
virulent phages.
Phage categories in viral fractions
The viral fraction in the feces of healthy humans appears to be
dominated by temperate phages, in sharp contrast with aquatic
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FIGURE 1 | (A) The lytic and lysogenic life cycles of phages (scheme taken
from Dr Gary Kaiser, with permission). Virulent phages perform only lytic
cycles (steps 1 to 5), they adsorb to the bacterial surface (1), inject their
DNA (2), replicate it (3), produce capsid proteins that assemble together (4),
and finally lyse their host (5). Temperate phages can proceed similarly or
shift to a lysogenic cycle (6), where they enter a silent stage of prophage
(usually integrated into the bacterial genome), and are replicated passively
by the bacterial machinery (7). Either a rare stochastic event or a stress
induces the prophage (8), which then comes back into a lytic cycle. (B). The
various states of a poly-lysogen strain. Most bacterial strains are
poly-lysogens, they host more than one prophage. As a consequence, a
population may differentiate into various states: it can produce (1)
background levels of virions, (2) excise some prophage and reveal a new
phenotype by restoration of the gene interrupted by the prophage
[producing for instance a surface protein, yellow square (Rabinovich et al.,
2012)], (3) adsorb virions and use them as virulence factors (Mitchell et al.,
2007).
environments where virulent phages dominate (Reyes et al.,
2010). These conclusions are drawn from the abundance, in feces
viromes, of integrase gene sequences, the enzyme being responsi-
ble for phage integration into the bacterial genome, and therefore
constituting a signature of temperate phages: about 1% of reads
from feces viromes map to integrases (Reyes et al., 2010), which
suggests that at least 50% of phages in the sample are temper-
ate (assuming that a 1 kb-long integrase gene constitutes 2% of
a 50 kb temperate phage). In another study of feces viromes,
a slightly different analysis also reported that 2.4% of contigs
of at least 1 kb possess an integrase gene (Minot et al., 2011).
Whether this proportion is altered in the microbiota of patients
suffering from diarrhea or other bowel diseases is still unknown.
An indication however comes from two reports on coliphages
(phages infecting Escherichia coli), where feces samples from trav-
eler’s diarrhea patients were found to contain higher titers of
coliphages compared to healthy individuals stools, and the phages
were mostly virulent in the patients, whereas they were mostly
temperate in samples from healthy controls (Furuse et al., 1983;
Chibani-Chennoufi et al., 2004).
Phage diversity
Virome studies allow for the first time to apprehend the over-
all phage genomic diversity, which is even greater than bacterial
genomic diversity (Kristensen et al., 2013). It should be noted
however, that phage genomic diversity is lower in fecal samples
compared to that observed in open environments, as has already
been observed for bacterial diversity (Ley et al., 2006). Diversity
estimations computed with the same index in five environments
are shown in Figure 2. The ratio of virotypes to bacterial phy-
lotypes in the fecal microbiota was estimated to be close to 1
(Reyes et al., 2010). Still, phage genomic diversity is huge in the
gut microbiota, and since most metagenomic phage sequences
do not map to known phage genes, the functional analysis of
viromes remains particularly difficult at present. Further advance
in this new field of science will certainly allow refining the pic-
ture in the coming years. The analysis of the virome of twins and
their mothers has shown that each individual has his own com-
plement of phages, regardless of genetic proximity (Reyes et al.,
2010). However, the viral fraction of a given individual remains
stable over time in a 1 year study (Reyes et al., 2010). Interestingly,
each individual virome is often dominated by one or a few phages
(Reyes et al., 2010; Minot et al., 2011).
Phage particle quantities
As important as phage diversity, but much less reported, is
the number of phage particles encountered in a given sample.
Estimates of phage and bacteria concentrations are nevertheless
key to the understanding of the phage roles in an ecosystem.
“Virus like particles” (VLP) counts are based on fluorescent dye
labeling of the samples, followed by microscopic analysis. In
aquatic environments where numbers with this technique were
first reported (Bergh et al., 1989), VLP counts vary with sea-
son and location, but often outnumber bacteria by 3- to 50-fold
(Wommack and Colwell, 2000). To simplify a complex reality,
bacterial titers in aquatic environments are said to be in the
106/ml range, and VLP around 10-fold more numerous. In the
gut of mammals, bacterial density increases along the digestive
tract, from an almost sterile situation in the stomach, up to 1010–
1011 per gram of material in the colon or in feces (Berg, 1996).
Compared with this dense bacterial population in the terminal
part of the gut, VLP concentrations in feces appear to be much
lower: estimates of 108 per gram of feces in infant is reported
(Breitbart et al., 2008), and another report in adults estimates val-
ues between 108 and 109 per gram of feces (Kim et al., 2011). In
the bovine ruminal fluid, counts between 107 and 108 VLP/ml
have been reported (Letarov and Kulikov, 2009) and references
therein. These numbers might be underestimated, as VLP may
bind to food particles, bacteria or other surfaces, and therefore
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FIGURE 2 | Phage richness in various viromes. Scores estimated with
PHACCS in five environments are shown (blue, open environments,
orange, human samples). PHACCS is a program estimating species
richness from contig spectra (Angly et al., 2005). Ocean: mix of four oceans
samples (Angly et al., 2006). Hot springs: Yellowstone (Schoenfeld et al.,
2008), saliva: average of 5 subjects (Pride et al., 2012), lung: non-cystic
fibrosis samples (Willner et al., 2009), feces: median value of 12 samples
(Reyes et al., 2010).
may not be efficiently detected. If such low titers of phages in
human feces are confirmed in the future, with potentially bet-
ter techniques, this might indicate that in the lower part of the
intestine, the phages encountered are mainly those sporadically
produced by bacteria hosting prophages, as is observed upon
culturing such bacteria in vitro (see above). The situation may
be different in the upper parts of the intestine: a study in the
mouse intestine reports ranges from 2 to 8× 109 phages per
gram of sample, and finds that phages exceed bacteria by 4-fold
(Barr et al., 2013). Moreover, in an experiment designed to test
the feasibility of eliminating an Escherichia coli population with
virulent phages in the mouse digestive tract, it was observed that
phages proliferated more in the upper portion of the gut (duode-
num) than in the lower part (Maura et al., 2012). This tendency
to proliferate in the upper tract may be related to the physiologi-
cal state of E. coli, which multiplies more in this gut section in the
animal model used.
Importance of the gut environment structure for phage development
Theoretical studies have highlighted that phage dynamics is
expected to be radically different if the environment is structured
rather than homogeneous, such as in mixed aqueous solutions
(Heilmann et al., 2012). This has been validated by experiments
comparing phage behavior in liquid medium and semi-solid agar:
the phage multiplies more readily on agar (Gama et al., 2013),
which may be due to the facilitated bacterium-phage contacts
within an agar matrix. Despite the mixing action of intestinal
peristalsis, the gut is a structured environment, in which differ-
ent compartments can be distinguished lengthwise and crosswise.
Within each longitudinal segment, at least three compartments
can be distinguished: the mucus layer, the lumen, and the food
particles, on which bacteria probably grow as biofilms (Brussow,
2013). It was recently shown in mice that some phage particles are
4-fold more concentrated in mucus layer compared to the lumen
content (Barr et al., 2013). The authors propose that this situation
may favor the host protection against the bacterial species these
phages prey on. As for the estimation of VLP concentrations,
the technical difficulties linked with the recovery of the distinct
tractus compartments should be underlined, and may explain
inconsistencies between studies. The mucus forms two layers, the
outer one being less structured and more accessible to bacteria
and phages, but alsomore difficult to keep intact. Before the use of
the Carnoy protocol (Swidsinski et al., 2005), mucus fixation did
not permit recovery of this loose layer of themucus. Clearly, much
remains to be investigated along these lines to better apprehend
the distribution of phages in the gut.
In addition to these spatial compartments, water content, pH
and oxygen concentration vary greatly according to the gut seg-
ment. Most of the water absorption takes place in the large bowel,
so that in the distal colon, the lumen content is much less liq-
uid than higher in the GI tract. This parameter may influence the
replication of phages, and explain why they tend to replicate better
in the upper tract.
PHAGES AND DYSBIOSIS
Phage infection in the gut may be widespread, as suggested by
the presence of abundant phage spacers in the CRISPR (clustered
regularly interspaced short palindromic repeat) systems of many
human gut bacteria (Stern et al., 2012). But very few data exist
so far concerning their role in microbiota functioning and in dys-
biosis more specifically. Here we review the ways by which phages
can impact a bacterial ecosystem with a focus on gut microbiota.
Firstly, phages can impact bacterial ecosystems by predation and
multiplication on susceptible bacteria (models 1 and 2, below).
Temperate phages can also lyse their previously lysogenic host
upon induction (model 3). Alternatively, temperate phages could
also impact the ecosystem without killing bacteria, by carry-
ing genes modifying bacterial phenotypes (model 4 in the next
section: “emergence of new bacterial strains”).
Model 1: “ Kill the winner” (Figure 3A)
Most of the knowledge concerning the impact of phages on
bacterial population through predation comes from studies in
the oceans and laboratory models. As phages cannot actively
move toward their bacterial preys, they rely entirely on chance to
encounter their hosts through random collision, and their ability
to infect and reproduce is determined by host density. Both exper-
iments and theory have shown that for a population of phages to
multiply, the bacterial population must be above a critical den-
sity termed the “replication threshold.” Below this density, the
probability of infection is lower than the probability of the phage
being lost (Wiggins and Alexander, 1985). As a consequence,
phage ability to multiply is possible only if the population of
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bacterial prey is high, a concept known as the “kill the winner”
model, meaning that phage killing concerns only the dominant
members of an ecosystem. This model is analogous to classical
Lotka–Volterra dynamics that describe predator–prey population
dynamics in ecology. Despite the popularity of this concept, only
rare demonstrations of this phenomenon exist. Observations of
phages/hosts ratios in ocean have confirmed for some bacterial
species that phage and host populations indeed oscillate coordi-
nately with time (Hennes and Simon, 1995; Parsons et al., 2012).
In the gut however, global studies of phage/bacteria covariation
with time have failed to detect any oscillation indicative of a “kill
the winner” dynamics, either in humans (Reyes et al., 2010), in
pigs (Allen et al., 2011), or in horses (Golomidova et al., 2007).
Such dynamics may nevertheless occur but escape observation at
the global level, if it concerns limited numbers of sub-dominant
species of the gut ecosystem. Moreover, this dynamics could not
be detected in monoxenic mice, harboring a microbiota com-
posed exclusively of E. coli and coliphages (Ando et al., 1979;
Weiss et al., 2009). Several factors could explain this marked
difference between gut and aquatic ecosystems, notably the struc-
tured semi-solid characteristic of the gut environment, enabling a
fraction of the bacterial population to be protected from phages
in physical or physiological refuges. Indeed, an attempt at killing
a simplified 15-member microbiota by phage cocktails purified
from human feces proved successful on two species of this ecosys-
tem during a period of 4–8 days. Later on, the two species were
found to have again reached their initial equilibrium concentra-
tions. Contrary to expectations, no phage resistant variants were
found in the late growing samples of these strains. This led the
authors to suspect, among other possibilities, a phenomenon of
refuge, whereby a fraction of the bacteria escaped phage infection
(Reyes et al., 2013).
Model 2: “biological weapon” or “kill the relative” model
(Figure 3B)
Even limited killing of a population of bacteria will cause a par-
tial niche emptying and give an advantage to the competitors
capable of exploiting the same niche. Thus bacteria can use their
prophages as biological weapons against their main competi-
tors, related bacteria that use the same ecological niche (Bossi
et al., 2003; Brown et al., 2006). Rare, spontaneous prophage
induction in a small fraction of the lysogenic population can trig-
ger an epidemic among susceptible bacterial competitors, which
become factories producing more phage. As the prophage pro-
vides immunity to its carrier bacteria against further infection
by this phage, the lysogenic bacteria are protected. Thus, by
killing competitor bacteria, prophages can indirectly benefit their
bacterial host. Virion amplification allows lysogenic bacteria to
invade well mixed populations of susceptible bacteria. It has been
demonstrated that such amplification is even faster when lyso-
gens are rare at the onset of the experiment (Brown et al., 2006).
Sometimes, however, temperate viruses spare recipient cells from
death by lysogenizing them, and, for some phages such as λ,
the probability of lysogenization increases with the multiplicity
of infection. Therefore, phage amplification leads to conflicting
predictions about the efficacy of temperate phages as biological
weapons: amplification can increase the relative advantage of the
lysogenic clone but it also increases the likelihood of saving sus-
ceptible cells from death by lysogenization (Gama et al., 2013).
Massive lysogenization of susceptible cells occurs in structured
environments, under the conditions of substantial phage growth,
resulting in a very transient advantage for the lysogenic bacteria
(Gama et al., 2013). Competition experiments between lysogen
and sensitive strains of Enterococcus faecalis in monoxenic mice
show a transient and limited, 1.5-fold enrichment of the lysogen
over the sensitive strain at 24 h, but no further time point was
shown (Duerkop et al., 2012). In summary, in complex microbial
communities, where susceptible bacteria are scarce, such “biolog-
ical weapon” phenomenon is thus likely to confer only a limited
advantage to lysogenic bacteria during colonization. It might have
an important role however, in protecting the microbiota from
invasion by a pathogenic strain, which may be killed by such
“weapons,” in keeping with the hypothesis of Barr et al. (2013).
Further experimental work is needed to address this question.
Model 3: community shuffling model (Figure 3C)
Rather than being beneficial to their bacterial host, prophages can
also be detrimental as their induction results in host lysis. Even
if spontaneous induction is a rare event with negligible adverse
consequence on lysogen fitness, a variety of environmental fac-
tors can change induction from a rare and stochastic event to
a deterministic process. In oceans, prophages have been com-
pared to molecular time bombs that can be triggered by changes
in salinity or by various pollutants (Paul, 2008). In the gut, sev-
eral inducing agents can potentially trigger prophage induction.
For example, some antibiotics at sub-inhibitory concentrations,
such as quinolones or beta-lactams, have been shown to induce
prophages in several bacterial species such as E. coli (Zhang
et al., 2000), Clostridium difficile (Meessen-Pinard et al., 2012),
E. faecalis (Matos et al., 2013), or Staphylococcus aureus (Goerke
et al., 2006; Maiques et al., 2006). Other toxic compounds such
as those present in cigarette smoke have been shown to induce
Lactobacillus prophages in vitro. This suggests a causal relation
between prophage induction by cigarette smoke and the higher
risk for smokers to contract bacterial vaginosis, which is charac-
terized by a reduction of vaginal lactobacilli (Pavlova and Tao,
2000). Oxidative stress is another potent inducer of phages in
the gut. Streptococcus pneumoniae produces naturally high levels
of H2O2 that were shown, in the nasopharynx, to be respon-
sible for prophage induction and killing of S. aureus lysogenic
strains, with no adverse effect on non-lysogens (Selva et al., 2009).
Inflammation, notably by provoking oxidative stress, might also
be responsible for prophage induction. Analysis of colonoscopy
biopsies have shown that the mucus of Crohn’s disease patients
was 30-fold enriched in virus-like particles (3× 109 VLP/biopsy
versus 108 for healthy controls (Lepage et al., 2008). Even in the
absence of external signal or inflammation, the stx2 carrying E.
coli prophage 933 W is more induced in the gut of monoxenic
mice than in vitro (Tyler et al., 2013). In E. coli and Lactobacillus
genomes, the vast majority of prophages are defective, indicat-
ing an active selection against prophages induction (Martin et al.,
2009). This suggests that prior to inactivation, these prophages
were induced at levels sufficiently high to favor the emergence
of defective variants. Consequences of prophage induction in the
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gut microbiota can be far reaching. Mills and coworkers have
proposed the “community shuffling” model which hypothesizes
that upon a stress, prophages can be more induced in mutu-
alistic intestinal bacteria than in opportunist pathogen species,
contributing to intestinal dysbiosis by diminishing the ratio of
symbionts to pathobionts (Mills et al., 2013). The role of bacte-
riophages in inflammatory bowel diseases has been suspected for
years and several mechanisms can be hypothesized (Riley, 2004),
notably the modification of the equilibrium between specific
bacterial populations.
PHAGES AND EMERGENCE OF NEW BACTERIAL STRAINS IN THE GUT
(MODEL 4)
The three above mentioned phage behaviors rely on the capacity
of phages to lyse their host. But temperate phages can also propa-
gate by establishing lysogeny into the host they infect, rather than
lysing it. Under laboratory conditions, the phage λ tends to enter
into the lysis cycle upon infection of an exponentially growing
bacterial cell. However, slow growing bacteria, or high multiplic-
ity of infection, are parameters that increase the proportion of
lysogens. Whether the lytic or the lysogenic cycle is favored in
natural ecosystems is unknown at present, and it will probably
depend on the phage, the bacterium, and the ecosystem tested. If
lysogeny is favored, the phages should be essentially considered
as horizontal transfer vectors that may considerably contribute to
the evolution of bacterial strains. An understanding of the relative
importance of lysis and lysogeny in various natural environments,
in particular that of the human gut, is vital to the understanding
of the phage-bacterial ecosystem. For this reason, it is important
in the future to design experiments aimed at estimating the lyso-
genization rate of various phages in natural environments. An
important alternative to the above mentioned “kill the relative”
(Figure 3B) model is therefore an “invade the relative” situation
(Figure 3D), whereby prophages behave as rampant invaders, and
thereby contribute to the emergence of new bacterial strains.
Such horizontal transfer might be neutral in terms of selec-
tion if the prophage does not change the bacterial phenotype.
But data accumulate that suggest on the contrary that prophages,
and even defective prophages, do change important bacterial phe-
notypes, often related to a shift toward pathogenicity, such as
increased virulence due to toxin production, or improved host
colonization, due to resistance to oxidative stress, bile salts, or
biofilm formation (Wang et al., 2010). In many cases, the phage
genes responsible for the phenotypes are known. Most of them
are “morons” (they bring something “more” to their host), mean-
ing that they have autonomous transcription signals, and are
expressed in the lysogenic state (Juhala et al., 2000). Except for
a few cases (Shiga-toxin and Pbl), the phage encoded toxins usu-
ally belong to this moron category (Brussow et al., 2004; Tinsley
et al., 2006). Interestingly, bio-informatics studies suggest that
many more morons are present in phage genomes, for which at
present no function can be predicted (Tobe et al., 2006).
Recently, several metagenomic studies have underlined the
presence of some antibiotic resistance genes in the virome frac-
tion (Allen et al., 2011; Colomer-Lluch et al., 2011; Fancello et al.,
2011;Minot et al., 2011;Modi et al., 2013). This contrasts with the
knowledge based on complete phage genomes, where antibiotic
resistance genes have been scarcely reported. When found, they
are associated with transposons (Banks et al., 2003) or insertion
sequences (Muniesa et al., 2004) that have invaded the phage
genome, a situation often correlated with phage decay (De Paepe
et al., 2014). It is also known that some phages encapsidate and
transfer large bacterial DNA segments from strain to strain, a pro-
cess named generalized transduction. A recent survey of various
viromes has established that such bacterial sequences were found
at low concentrations in most samples extracted from eukaryotic
environments (Roux et al., 2013). This process contributes to the
spread of antibiotic resistance genes (Muniesa et al., 2004, and
references therein). Whether the few antibiotic genes reported
in various viromes correspond to these two well known mecha-
nisms, or indicate a new process that has escaped earlier scrutiny
remains to be investigated.
A last aspect of the contribution of phages to the emergence
of more virulent strains is related to their remarkable capac-
ity of evolution: they mutate and recombine at rates orders of
magnitude higher than bacteria (Drake, 1999; Martinsohn et al.,
2008; De Paepe et al., 2014). Temperate phages also efficiently
exchange sequences with defective phage remnants present in the
host in which they multiply (De Paepe et al., 2014). New phages
are therefore constantly emerging, with new assortments of gene
sequences. Horizontal transfer mediated by phages is therefore
more than the simple passage of a given genetic content from
one host to the next, but it is likely to contribute actively to the
generation of new gene—and genome—combinations.
IMPACT OF PHAGES ON HOST IMMUNITY
Mammals and their intestinal microbes live in a symbiotic rela-
tionship. Host tolerance toward its intestinal microbiota is facili-
tated through physical separation of bacteria and host cells via the
mucus layer, by bacterial adaptation to reduce its immunogenic-
ity, and by direct modulation of local host immune responses,
through, among other mechanisms, the release of bacterial
metabolites that are yet to be fully characterized (Arpaia et al.,
2013; An et al., 2014). Our knowledge of how phages contribute
to these interactions is still limited.
Among the mechanisms responsible for the recognition of
microbial and viral structures are the Toll Like Receptors (for a
review see Kawai and Akira, 2011). Ten and twelve TLRs have
been described, in mouse and humans respectively, that recognize
Pathogen Associated Molecular Patterns (PAMP) including LPS,
unmethylated CpG-DNA and flagellin notably.
Viral nucleic acids act as PAMPs and are recognized by mul-
tiple TLRs. TLR3, TLR7, TLR8, and TLR9 are involved in the
recognition of viral nucleotides such as double-stranded RNA
(dsRNA) (TLR3), single-stranded RNA (ssRNA) (TLR7-TLR8),
and DNA (TLR9) (Alexopoulos et al., 2010; Blasius and Beutler,
2010; Shi et al., 2011). The hallmark of these nucleic acid-sensing
TLRs is that they potently promote the production of type I IFN,
in addition to the other inflammatory cytokines that are induced
by all TLRs. So far no TLR recognizing specific phage compo-
nents have been described, but they could have a cell surface or
intracellular location. TLR1, TLR2, TLR4, TLR5, and TLR6 are
localized on the cell surface and largely recognize microbial mem-
brane components whereas TLR3, TLR7, TLR8, and TLR9 are
Frontiers in Cellular and Infection Microbiology www.frontiersin.org March 2014 | Volume 4 | Article 39 | 6
De Paepe et al. Phages and pathobionts
FIGURE 3 | (A) In the Kill the winner scheme, viruses are more abundant
than bacteria, but do not infect them because of their low concentration (step
1). However, if some bacteria overgrow (step 2), and reach the threshold
above which phages can absorb and predate them, they will lyse, and the
system will shift back to its initial state (3). (B) In the Kill the relative
scheme, phages do not need to be abundant, they are produced by lysogen
strains (step 1) and kill their relatives that are not resistant to the phage
(bacteria of the same color, but lighter, with a “-”label). The net result is an
advantage of lysogenic populations relative to non-lysogens (step 2). (C) In
the Community shuffling scenario, temperate phages act negatively on
their host by killing them upon sensing a mild stress that would not have
killed a non-lysogen (step 2). A positive feed-back loop may even take place if
the massive lysis leads to an host reaction, such as inflammation (orange
arrow). The net result is a global displacement of population, and possibly
dysbiosis. (D) Temperate phages can act profoundly on bacterial population
without lysing them: in the Invade the relative scheme, the prophage
propagates itself by infecting new hosts without lysing them, but by
establishing lysogeny (step 2, the + sign indicates new lysogens).
expressed within intracellular vesicles and recognize nucleic acids
(Blasius and Beutler, 2010).
Three main interaction mechanisms between phage and the
immune system have been described or suggested:
Prophage-mediated changes of recognition patterns of bacteria
Riley hypothesized in 2004 that phages might be involved
in inflammatory bowel disease pathogenesis by changing the
recognition patterns of bacteria (Riley, 2004). Indeed, it has
been demonstrated for Salmonella, E. coli, Shigella, and Vibrio
cholerae that some temperate phages encode enzymes modifying
the O-antigen component of the bacterial host outer mem-
brane lipopolysaccharide (LPS), modifying bacterial antigenicity
(Verma et al., 1991; Boyd et al., 2012; Brussow, 2013; Davies et al.,
2013). Thanks to their prophages, some lysogenic bacteria could
then escape the immune system, with radically different outcomes
depending on whether the bacteria belong to commensal or
pathogenic species.
Direct immunity modulation upon phage particles phagocytosis
In addition, phages could be directly recognized by the host and
trigger specific modulations. As suggested recently, bacteriophage
recognition by antiviral innate immune sensors would happen
if cells directly phagocytized phage particles or if phages were
delivered to the intracellular environment by phage-producing
bacteria (Duerkop and Hooper, 2013). After degradation of the
phage particle, phagocytized phage nucleic acids could be sensed
by endosomal receptors (TLR7 or TLR9). If intracellular phages
are uncoated in the cytoplasm, the released nucleic acids could be
sensed by the sensors cGAMP synthase (DNA) or RIG-I (RNA),
which signal through stimulator of interferon genes and mito-
chondrial antiviral-signaling protein, respectively. The cascade
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leads to NF-κB, IRF3 and IRF7 which promote the transcrip-
tion of immune effectors such as IFN-β and proinflammatory
cytokines.
Phages particles interacting with the mucus
Recently, the F. Rohwer team described how the Ig-like domain of
the T4 phage Hoc capsid protein could bind mucus (Barr et al.,
2013). Because this protein has been detected as abundant in
viromes, and highly variable, such interactions are suggested to
occur frequently in the human intestine.
A better understanding of the impact of phages on immu-
nity should help for the development of techniques such as fecal
transplants, whereby a complete microbiota from an healthy indi-
vidual is inoculated to a patient with severe colitis (often due to
Clostridium difficile infection). Fecal transplants have been shown
to represent an alternative therapy to restore eubiosis, a balanced
microbial ecosystem in the human gut (Allen-Vercoe et al., 2012;
Kelly, 2013). However, among the limits that restrain its use, is the
fact that phages and viruses are also transferred during the pro-
cedure. While inoculum/samples can be typed for the presence of
known human and animal viruses, the important biomass, gene
pool and potential immuno-modulatory signals represented by
phages have yet to be characterized. The impact of phages on
the immune system is also actively investigated by teams work-
ing on phage therapy. Even though the phages used, and the
doses applied, differ significantly from the conditions encoun-
tered in natural ecosystems, the effects observed are informative.
No major adverse or stimulatory effects have been reported so far,
following massive ingestion of phage preparations (Gorski et al.,
2012; McCallin et al., 2013; Miernikiewicz et al., 2013).
CONCLUSION
Phages play important and diverse roles in all bacterial ecosys-
tems, but their precise impact on the gut microbiota is far from
being understood. Present as the major component in most
ecosystems, generally outnumbering bacteria by a factor of 10,
they appear to be less numerous in the intestine where fecal VLP
counts are of the order of 108/g compared to bacterial counts a
thousand-fold greater. It is equally interesting that the gut envi-
ronment differs from most other ecosystems in containing a
majority of temperate phages—though virulent phages are found.
These temperate bacteriophages presumably result from sponta-
neous induction, and thus exist mostly as prophages integrated
into the bacterial genomes. This finding influences the inter-
pretation of results of experiments to unravel the complexities
of bacteriophage-host dynamics in the gut. In the relatively few
investigations published to date, little evidence has been found
for models invoking a massive killing action of bacteriophages
on bacterial populations in the intestinal ecosystem; experiments
have shown evidence neither for the cyclical variations of popu-
lation density typical of a predator-prey relationship, nor for an
advantage to lysogenic bacteria in killing non-lysogenic competi-
tors as a result of low-level phage release (“biological weapons”).
It might be that the action of bacteriophages on the equilibrium
of the gut ecosystem is due to a large extent to their mode of
existence as prophages. This conclusion would be in keeping with
the importance of prophages in the gut metagenome, where they
make up a sizeable proportion (from a few percent to over 10%)
of any bacterial genome.
The presence of an active prophage has two major implica-
tions for the bacterium. Firstly it may bring a higher sensitivity
to antibiotics, some of which are known to induce lytic growth.
Other stresses inducing lysogenic bacteriophages may include
inflammation caused by travelers’ and Crohn’s disease, which
have been reported to increase counts of VLP in patients’ stools.
Such induction may result, for example, in “community shuf-
fling” by killing lysogens and thus open niches to colonization
by other strains or species. But the most important contribution
of bacteriophages to the gut ecosystem is probably their function
as vectors of virulence and more generally of adaptation genes,
whereby they contribute to a reassortment of virulence factors
which results in the creation of new, virulent strains.
Though a number of high-quality investigations have recently
been published, interest in the role of bacteriophages in modu-
lating the equilibrium of the gut ecosystem is relatively recent,
and the knowledge base correspondingly scant. Indeed, though
the existing evidence argues for a more important role of cer-
tain of the phage-host interactions exposed in this review, there
is little data on which to base a solid hypothesis. In the future,
metagenomic approaches, with their potential to determine sep-
arately the content in both bacteria and bacteriophages, will
certainly provide important information on the role of bacte-
riophages, and notably on their potential impact on dysbiosis.
To elucidate the contribution of the various models presented
in this review, a critical point will be to estimate VLP numbers
in order to verify whether the global amount of phages increases
or not during disease-associated shifts in species composition of
the microbiota. If this observation is indeed confirmed, biological
experiments will be required in order to determine the direction
(or directions) of causality in this association. Studies performed
on animal models allow the manipulation of a simplified micro-
biota, composed of known strains of commensals, pathogens
and/or probiotics, containing (or not) known prophages. Such
models have already been used to investigate the dynamics of the
phage-bacteria ecosystem (killing, lysogenization, passage of the
bacteriophage from one strain to another). The development of
these models will allow further investigation of the phage bac-
teria dynamics and, importantly, the monitoring of the effect
of various stresses on prophage induction and population com-
position (possible dysbiosis). Another, relatively simplified gut
ecosystem, though not artificial, is the immature microbiota of
human newborns. Following the fate of phages and bacteria in
this microbiota, less diverse than that of the adult, may lead
to a better understanding of the dynamics of phages and bac-
teria, as well as their potential perturbations during bacterial
or viral infections. More generally, virome analyses should be
included in the protocols used in longitudinal studies on the
microbiota of human cohorts. Apart fromDNA-based analyses of
the virome, phage proteins or phage-related metabolites may pro-
vide important insights. Such components produced by a stressed
microbiota may be produced before any shift in the ecosystem
composition, and thus constitute markers capable of anticipating
dysbiosis.
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Though our understanding of the involvement of bacterio-
phages in the equilibrium of the intestinal microbiota remains
partial, the existing data on phages in human or animal-
associated microbiota have established their importance, both
as vectors of pathogenicity factors in the emergence of virulent
strains and as dynamic players in the intestinal ecosystem. Several
pioneering investigations have recently begun to decipher the
dynamics of phage-bacterium interactions and suggest avenues
of research into how they may maintain homoeostasis, favor a
shift to dysbiosis, or the overgrowth of opportunist pathogens.
Building upon these results, in the next decade the development
and optimization of high-throughput ‘omics analyses combined
with biological data from constantly refined animal models and
comparative volunteer studies will allow important advances in
the comprehension of the part played by phages in the gut ecosys-
tem, with the potential for equally great advances in prevention
and therapy of intestinal disorders.
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